Apimeds Pharmaceuticals Us, INC. 8-K/A Filing
Ticker: APUS · Form: 8-K/A · Filed: Apr 9, 2026 · CIK: 0001894525
| Field | Detail |
|---|---|
| Company | Apimeds Pharmaceuticals Us, INC. (APUS) |
| Form Type | 8-K/A |
| Filed Date | Apr 9, 2026 |
| Sentiment | neutral |
Sentiment: neutral
FAQ
What type of filing is this?
This is a 8-K/A filing submitted by Apimeds Pharmaceuticals Us, INC. (ticker: APUS) to the SEC on Apr 9, 2026.
Where can I view the full 8-K/A filing?
The complete filing is available on SEC EDGAR. You can also read the AI-decoded analysis with risk assessment and key highlights on ReadTheFiling.
Filing Details
This Form 8-K/A (Form 8-K/A) was filed with the SEC on April 9, 2026 regarding Apimeds Pharmaceuticals US, Inc. (APUS).